Antimicrobial Resistance News and Research

RSS

Researchers map unknown microorganisms in human intestinal flora

Researchers from DTU Systems Biology have mapped 500 previously unknown microorganisms in human intestinal flora as well as 800 also unknown bacterial viruses (also called bacteriophages) which attack intestinal bacteria.

7 Jul 2014

Antibiotic therapy: A potential game-changer for hemodialysis treatment

An antibiotic therapy known to reduce catheter-related bloodstream infections in hemodialysis patients has been shown for the first time to reduce mortality, according to a Henry Ford Health System study.

3 Jul 2014

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

Synthetic Biologics, Inc., a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today the formation of a Clinical Advisory Board (CAB) to support development of SYN-004, the Company's lead anti-infective product candidate for the prevention of the devastating effects of Clostridium difficile (C. difficile)

30 Jun 2014

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

A new research project (PneumoNP) is aimed at tackling antibiotic resistance in respiratory tract infections via the use of inhalable nanotherapeutic compounds. Funded under the FP7 programme by the European Commission, the 4-year long PneumoNP project brings together top research institutes, universities, clinicians and enterprises from 6 EU member states.

28 Jun 2014

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Scientists at the University at Buffalo are turning to an old class of antibiotics to fight new superbugs resistant to modern medicine.

24 Jun 2014

Education campaign fails to improve guideline adherence in paediatric AOM

Swedish researchers report that overall adherence to treatment guidelines for acute otitis media in children is good, at 70–90%, but that adherence to watchful waiting is poor.

23 Jun 2014

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

Cubist Pharmaceuticals, Inc. announced today the U.S. Food and Drug Administration approved SIVEXTRO (tedizolid phosphate) for the treatment of adult acute bacterial skin and skin structure infections (ABSSSI).

21 Jun 2014

New antibiotic proves effective in treating serious bacterial skin and skin-structure infections

A study published in today's New England Journal of Medicine reports that the antibiotic dalbavancin is as effective as vancomycin, the current standard-of-care antibiotic used to treat serious bacterial skin and skin-structure infections.

5 Jun 2014

Growing resistance to antibiotics demands a coordinated global response, say experts

Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, experts say.

23 May 2014

Viewpoints: heath insurance and mortality; newly insured vs. previously insured on marketplaces

The connection between health insurance and mortality is really hard to pin down, even if insurance truly has strong protective effects. The uninsured in America are mainly non-elderly adults.

13 May 2014

Long-term use of drug combination reduces risk of recurrent urinary tract infection in children

Long-term use of a drug combination reduces the risk of recurrent urinary tract infection by up to 80 percent in children with the urinary condition vesicoureteral reflux compared to placebo, according to research funded by the National Institutes of Health.

5 May 2014

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Cubist Pharmaceuticals, Inc. today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration for approval of its investigational antibiotic ceftolozane/tazobactam for the treatment of Complicated Urinary Tract Infections (cUTI) and Complicated Intra-Abdominal Infections (cIAI).

21 Apr 2014

Researchers identify novel vancomycin-resistant MRSA superbug in Brazil

An international research team led by Cesar A. Arias, M.D., Ph.D., at The University of Texas Health Science Center at Houston has identified a new superbug that caused a bloodstream infection in a Brazilian patient. The report appeared in the April 17 issue of The New England Journal of Medicine.

17 Apr 2014

JPIAMR outlines steps to minimise antimicrobial resistance

Antibiotics have saved millions of lives from once deadly infectious diseases. But, misuse of antibiotics and other antimicrobials in humans and animals has led to bacteria evolving resistance.

3 Apr 2014

Emergence of community-acquired infections due to ESBL-producing bacteria on the rise

The emergence of community-acquired infections, such as urinary tract infections (UTI), due to strains resistant to common antibiotics are on the rise, according to Rhode Island Hospital researchers. The study is published online in the journal Antimicrobial Resistance and Infection Control.

26 Mar 2014

Antimicrobial Resistance News and Research

Researchers map unknown microorganisms in human intestinal flora

Antibiotic therapy: A potential game-changer for hemodialysis treatment

Synthetic Biologics supports SYN-004 C.difficile preventative program with formation of Clinical Advisory Board

New research project aims to tackle antibiotic resistance with inhalable nanotherapeutics

Scientists turn to old class of antibiotics to fight superbugs resistant to modern medicine

Education campaign fails to improve guideline adherence in paediatric AOM

Cubist Pharmaceuticals' SIVEXTRO receives FDA approval for treatment of ABSSSI

New antibiotic proves effective in treating serious bacterial skin and skin-structure infections

Growing resistance to antibiotics demands a coordinated global response, say experts

Viewpoints: heath insurance and mortality; newly insured vs. previously insured on marketplaces

Long-term use of drug combination reduces risk of recurrent urinary tract infection in children

Cubist submits ceftolozane/tazobactam NDA for treatment of cUTI and cIAI

Researchers identify novel vancomycin-resistant MRSA superbug in Brazil

JPIAMR outlines steps to minimise antimicrobial resistance

Emergence of community-acquired infections due to ESBL-producing bacteria on the rise

New research commissioned to create infection control strategy for AMR and antibiotic usage

S. pneumoniae thrives in human saliva

Addressing antibiotic resistance: an interview with Professor Otto Cars, Uppsala University, Sweden

JHI releases epic3 guidelines on infection prevention for healthcare professionals

JHI released epic3 guidelines on infection prevention and control for range of healthcare professionals

Microbiology eBook

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News